// App-Quantinova.ai

: AT(N) Biomarker Profiles and Alzheimer’s Disease Clinical Status and Memory in Adults with Down syndrome

Researchers

Presenter

  • Sigan L Hartley

Principal Investigators

  • Dana L Tudorascu

  • Laise Lee

  • Melissa Petersen

  • Ann D Cohen

  • William E Klunk

  • Charles M Laymon

  • Shahid Zaman

  • Bradley T Christian

  • Benjamin L Handen

Medical Centers

  • Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health

  • KU Alzheimer's Disease Research Center

  • Waisman Center, University of Wisconsin, Madison

  • University of Texas Health Science Center, TX.

  • University of Wisconsin - Madison, School of Human Ecology

  • University of Pittsburgh, PA

  • 6. Department of Neurology University of Wisconsin-Madison School of Medicine and Public Health

  • Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House

  • Cambridgeshire & Peterborough NHS Foundation Trust, Fulbourn Hospital,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

  • Down syndrome

  • Dementia

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • AV-1451

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved